To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex)
Clinical trial NCT03521713 · UNKNOWN
Trial details
- NCT number
- NCT03521713
- Sponsor
- Dong-A ST Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2020-09-01
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.